Evidence map›Paper›PMID 37943170›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2024

The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council.

Robert Bissonnette, Eric Simpson, Lawrence F Eichenfield, Emma Guttman-Yassky, Jonathan I Silverberg, Lisa A Beck, Lorena Mija, Jacob P Thyssen, Thomas Bieber, Kenji Kabashima and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Robert BissonnetteInnovaderm Research Inc, Montréal, Quebec, Canada.ORCID https://orcid.org/0000-0001-5927-6587
Eric SimpsonOregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0003-0853-0252
Lawrence F EichenfieldUniversity of California San Diego School of Medicine and Rady Children's Hospital San Diego, San Diego, California, USA.
Emma Guttman-YasskyIcahn School of Medicine at Mount Sinai School of Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0002-9363-324X
Jonathan I SilverbergThe George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.ORCID https://orcid.org/0000-0003-3686-7805
Lisa A BeckUniversity of Rochester Medical Center, Rochester, New York, USA.ORCID https://orcid.org/0000-0002-8452-667X
Lorena MijaUniversity of Montreal, Montreal, Quebec, Canada.
Jacob P ThyssenDepartment of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-3770-1743
Thomas BieberUniversity Hospital Bonn, Germany and Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.
Kenji KabashimaKyoto University, Kyoto, Japan.
Elaine SiegfriedDepartments of Pediatrics and Dermatology, Cardinal Glennon Children's Hospital and Saint Louis University, Saint Louis, Missouri, USA.
Georg StinglMedical University of Vienna, Vienna, Austria.
Peter van de KerkhofRadboud University Medical Center, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0003-0084-3131
Gil YosipovitchUniversity of Miami, Miami, Florida, USA.
Carle PaulToulouse University, Toulouse, France.
Amy S PallerNorthwestern University Feinberg School of Medicine and Ann and Robert H Lurie Children's Hospital, Chicago, Illinois, USA.

Funding

A Community-based Assessment of Skin Care, Allergies, and Eczema: The CASCADE TrialR01AR071057 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SIMPSON, ERIC L · 2018 to 2023
$4.5M
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD PatientsU01AI152011 · NIAID · UNIVERSITY OF ROCHESTER · PI Lisa Ann Beck · 2020 to 2026
$3.2M
NIAID NIH HHS U01 AI152011NIAMS NIH HHS R01 AR071057
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dermatitis, AtopicEczemaHumansSeverity of Illness Index

Identifiers

PMID37943170
PMCPMC13236704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.